The warning label placed on all estrogen-based treatments since 2003 was based on an outdated and flawed government-funded study.

For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...

Perrysburg, Ohio – March 02, 2026 – PRESSADVANTAGE – ...

However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...

Sharlin Health and Neurology Clarifies Modern Hormone Therapy Standards in Springfield Ozark, United States - February ...

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...

Concurrent hormone therapy may augment the cardiometabolic benefits of tirzepatide, including improved blood pressure and lipid profiles.

Progress depends on the willingness to reassess long-held beliefs, prioritize patient-centered outcomes and ensure that modern care reflects what the science supports.

In July 2002, obstetrician-gynecologist JoAnn Pinkerton, MD, had just settled into her afternoon routine seeing patients at the University of Virginia Health Center when a nurse told her that several ...

Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of ...